Dexcom DXCM
NASDAQ DXCM
$90.22 +0.34 (+0.38%)
At close: Aug 20, 2026 · 4:00 PM EDT

Dexcom (DXCM) Accounts Payables (2011 - 2012)

Dexcom (DXCM) posted quarterly Accounts Payables of $3.9 million for Q4 2012, up 39.29% year-over-year from $2.8 million in Q1 2012, and up 2.74% quarter-over-quarter from $3.8 million in Q3 2012.

Dexcom (DXCM) Accounts Payables (2011 - 2012) Analysis & Trends

Dexcom (DXCM) has reported Accounts Payables for 2 consecutive years, with $3.9 million the latest figure, recorded in Q4 2012.

  • In Q4 2012, Accounts Payables rose 39.29% year-over-year to $3.9 million; the TTM figure through Dec 2012 stood at $3.9 million (up 39.29% YoY), while the FY2012 annual figure was $3.9 million, up 39.29% from the prior year.
  • Accounts Payables improved to $3.9 million in Q4 2012 per DXCM's latest filing, from $3.8 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $3.9 million in Q4 2012 and bottomed at $2.0 million in Q2 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 4.79 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 1.66 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 2.64 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 1.23 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 210.50 Mn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 3.23 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 2.42 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 344.10 Mn
10 Zimmer Biomet Holdings 19.04 Bn 18.63 Bn 1.54 Bn 352.40 Mn

Historic Data

Download Data
DateValue
Dec 31, 2012 3.90 Mn
Sep 30, 2012 3.80 Mn
Jun 30, 2012 2.02 Mn
Dec 31, 2011 2.80 Mn